M&A Critique

Search results for - pharmaceuticals

Cross Border News International News National News

M&A Happenings: February 2015

Industry-wise breakup of the schemes filed is as follows: Industry No. of Deals February 2015 January 2015 Auto Components 1 1 Financial Services 5 5 Investments 3 2 Information Technology 4 2 Infrastructure 2 0 Power 0...

M&A Happenings: January 2015

Industry-wise breakup of the schemes filed is as follows: Industry No. of Deals January 2015 December 2014 Auto Components 1 2 Financial Services 5 4 Investments 2 3 Information Technology 2 1 Infrastructure 0 2 Power 1...

M&A Happenings: December 2014

Industry-wise breakup of the schemes filed is as follows: Industry No. of Deals December 2014 November 2014 Auto Components 2 2 Financial Services 4 2 Investments 3 3 Information Technology 1 1 Infrastructure 2 1 Media...

Sun Pharma Acquires Ranbaxy

In April 2014, Sun Pharmaceutical acquired 100% of Ranbaxy Laboratories for $4 billion to create world’s fifth largest specialty generic pharma company. Under these agreements, Ranbaxy will merge into Sun Pharma and the...

Aurobindo Pharma Expands Overseas Operations

At a time when Aurobindo Pharma gets nearly two­third of its revenues from abroad, it is quite natural for the company to aggressively expand its operations globally. The company bought Dublin­based Actavis Plc’s...

Creating Value For Shareholder

Recently, the Board Of Directors of Pfizer Ltd. (“Pfizer India”) and Wyeth Ltd. (“Wyeth India”) had approved the long-awaited merger of Wyeth India into Pfizer India, which will create a single Pfizer brand in India. In...

Shriram Group Is The First Choice For Investors

Shri Ram Group Company has made investments in Manufacturing, Value Added Services, Project Development, Engineering Services, Pharmaceuticals, Machined & Auto Components, Press Dies & Sheet Metal Stamping...